Search Results for 'Biologics, Proteins, Vaccines'
Contract Service Directory Companies
Microsite Companies
View All Buyers Guide Companies »
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Industry News | Scale-up/Technology Transfer
AGC Biologics, Novavax Expand Coronavirus Vax Pact
Expands supply of Matrix-M adjuvant for Novavax’ coronavirus vaccine, NVX-CoV2373, from its facility in Seattle for U.S. supply.Contract Pharma Staff 08.11.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Saiba AG and AGC Biologics Enter COVID-19 Vaccine Partnership
AGC will manufacture SARS-CoV-2 vaccine for the Swiss biotechContract Pharma Staff 06.16.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Novavax Selects AGC Biologics to Manufacture Novel COVID-19 Vax
To provide large-scale GMP production of Matrix-M, the adjuvant component of Novavax’ coronavirus vaccine candidate, NVX-CoV2373.Contract Pharma Staff 06.03.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
GSK Partners with Samsung Biologics
Inks $231 million deal to secure additional manufacturing capacity for biopharmaceutical portfolioContract Pharma Staff 05.27.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Takara Bio, AGC Biologics Enter Plasmid DNA Mfg. Pact
AGC to manufacture plasmid DNA intermediate for COVID-19 vaccine candidate.Contract Pharma Staff 05.21.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
LakePharma Announces "New Frontiers in Biologics" Conference
The conference will be held on Friday, October 5, 2018 at the South San Francisco Conference Center, CA08.20.18
-
Biologics, Proteins, Vaccines
Trends and Challenges - Vaccines Manufacturing
Sartorius' Amelie Raveneau discusses manufacturing technologiesVideos
-
Biologics, Proteins, Vaccines | Drug Development | Drug Discovery | Scale-up/Technology Transfer
Catalent Biologics, PATH Partner on Malaria Vaccine Initiative
Aims to create antibodies for Malaria Vaccine using GPEx Cell Line Technology12.15.16
